Surgery – Blood drawn and replaced or treated and returned to body – Constituent removed from blood and remainder returned to body
Patent
1988-07-26
1993-05-11
Pellegrino, Stephen C.
Surgery
Blood drawn and replaced or treated and returned to body
Constituent removed from blood and remainder returned to body
604 4, 604 49, 604 52, A61M 3700
Patent
active
052097170
ABSTRACT:
Described are a method and a device for the application and the removal of locally applied active substances against solid tumors, which device consists of a catheter (1) to be positioned distally to the tumor for the collection of blood coming from the tumor, a pump (2) and a catheter (3) connected thereto and returning the blood into the body. The device is characterized in that between the two catheters (1, 3) there is present at least one container (4) capable of allowing blood to pass therethrough and containing immobilized substances having high affinity against the applied active substance.
REFERENCES:
patent: 4337760 (1982-07-01), Rubin
patent: 4605394 (1986-08-01), Skurkovich
patent: 4610662 (1986-09-01), Weikl et al.
patent: 4867742 (1989-09-01), Calderon
Howell, Seminars in Oncology, vol. XII, No. 3, Suppl. Sep. 4, 1985; pp. 17-22.
Clark, et al., J. Neurosurg. 62, 576-579 (1985).
Oldfield, et al., J. Neurosurg. 63, 726-732 (1985).
Oldfield, et al., Cancer Res. 47, 1962-1967 (1987).
Rote Liste, Zytostatica and Blocker of Methastases.
Bersani, Laura et al., "Involvement of Tumour Necrosis Factor in Monocyte-Mediated Rapid Killing of Actinomycin D-Pretreated WEHI 164 Sarcoma Cells", Immunology, vol. 59, pp. 323-326, 1986.
Aggarwal, Bharat B., et al., "Characterization of Receptors for Human Tumour Necrosis Factor and Their Regulation by .tau.-Interferon", Nature, vol. 318, Dec. 19-26, 1985.
Balkwill, Frances R., et al., "Human Tumor Xenografts Treated with Recombinant Human Tumor Necrosis Factor Alone or In Combination with Interferons", Cancer Research, vol. 46, pp. 3990-3993, Aug. 1986.
Fransen, Lucie, et al., "Recombinant Tumor Necrosis Factor: Its Effect and Its Synergism with Interferon-.tau. on a Variety of Normal and Transformed Human Cell Lines", Eur. J. Cancer Clin. Oncol., vol. 22, pp. 419-426, 1986.
Lax Edmund R.
Schmoll Ekkehard
Schmoll Hans-Joachim
Pellegrino Stephen C.
Pharma Biotechnologie Hannover GmbH
Rafa Michael
LandOfFree
Method and device for local application and removal of active su does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and device for local application and removal of active su, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and device for local application and removal of active su will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1346970